Medicaments for the treatment of chronic obstructive pulmonary disease


Ontology type: sgo:Patent     


Patent Info

DATE

2011-10-25T00:00

AUTHORS

KONETZKI INGO , SCHROMM KURT , SCHOLLENBERGER HERMANN , PESTEL SABINE , SCHNAPP ANDREAS , BOUYSSOU THIERRY , BUETTNER FRANK , HEINE CLAUDIA , LUSTENBERGER PHILIPP , HOENKE CHRISTOPH , RUDOLF KLAUS

ABSTRACT

A pharmaceutical composition comprising a compound of formula 1 wherein: n is 1 or 2;R1 is hydrogen, C1-C4-alkyl, halogen, OH, or —O—C1-C4-alkyl;R2 is hydrogen, C1-C4-alkyl, halogen, OH, or —O—C1-C4-alkyl;R3 is hydrogen, C1-C4-alkyl, OH, halogen, —O—C1-C4-alkyl, —O—C1-C4-alkylene-COOH, or —O—C1-C4-alkylene-CO—O—C1-C4-alkyl, or an acid addition salt thereof with a pharmacologically acceptable acid, or a solvate or hydrate thereof; and a pharmaceutically acceptable excipient or carrier, and methods for using the pharmaceutical formulation in the treatment of chronic obstructive pulmonary disease (COPD). More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/40", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/34", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3402", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "KONETZKI INGO", 
        "type": "Person"
      }, 
      {
        "name": "SCHROMM KURT", 
        "type": "Person"
      }, 
      {
        "name": "SCHOLLENBERGER HERMANN", 
        "type": "Person"
      }, 
      {
        "name": "PESTEL SABINE", 
        "type": "Person"
      }, 
      {
        "name": "SCHNAPP ANDREAS", 
        "type": "Person"
      }, 
      {
        "name": "BOUYSSOU THIERRY", 
        "type": "Person"
      }, 
      {
        "name": "BUETTNER FRANK", 
        "type": "Person"
      }, 
      {
        "name": "HEINE CLAUDIA", 
        "type": "Person"
      }, 
      {
        "name": "LUSTENBERGER PHILIPP", 
        "type": "Person"
      }, 
      {
        "name": "HOENKE CHRISTOPH", 
        "type": "Person"
      }, 
      {
        "name": "RUDOLF KLAUS", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/00002018-200427040-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008046870", 
          "https://doi.org/10.2165/00002018-200427040-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200427100-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048743769", 
          "https://doi.org/10.2165/00002018-200427100-00001"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-10-25T00:00", 
    "description": "

A pharmaceutical composition comprising a compound of formula 1

\n

\"embedded
\nwherein:\n

  • n is 1 or 2;
  • R1 is hydrogen, C1-C4-alkyl, halogen, OH, or —O—C1-C4-alkyl;
  • R2 is hydrogen, C1-C4-alkyl, halogen, OH, or —O—C1-C4-alkyl;
  • R3 is hydrogen, C1-C4-alkyl, OH, halogen, —O—C1-C4-alkyl, —O—C1-C4-alkylene-COOH, or —O—C1-C4-alkylene-CO—O—C1-C4-alkyl, or\n
    \nan acid addition salt thereof with a pharmacologically acceptable acid, or a solvate or hydrate thereof; and\n
    \na pharmaceutically acceptable excipient or carrier, and methods for using the pharmaceutical formulation in the treatment of chronic obstructive pulmonary disease (COPD).\n
\n

", "endDate": "2023-11-10", "id": "sg:patent.US-8044046-B2", "name": "Medicaments for the treatment of chronic obstructive pulmonary disease", "recipient": [ { "id": "http://www.grid.ac/institutes/grid.420061.1", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-8044046-B2" ], "sdDataset": "patents", "sdDatePublished": "2022-12-01T06:58", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/patent/patent_3.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-8044046-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-8044046-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-8044046-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-8044046-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

77 TRIPLES      15 PREDICATES      19 URIs      9 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-8044046-B2 schema:about anzsrc-for:34
2 anzsrc-for:3402
3 anzsrc-for:40
4 schema:author N7672950e87bd43738a4d22d2909d4442
5 schema:citation sg:pub.10.2165/00002018-200427040-00003
6 sg:pub.10.2165/00002018-200427100-00001
7 schema:datePublished 2011-10-25T00:00
8 schema:description <p num="p-0001">A pharmaceutical composition comprising a compound of formula 1</p> <p num="p-0002"><chemistry id="CHEM-US-00001" num="00001"><img id="EMI-C00001" he="32.43mm" wi="71.80mm" file="US08044046-20111025-C00001.TIF" alt="embedded image" img-content="chem" img-format="tif" orientation="portrait" inline="no"/><attachments><attachment idref="CHEM-US-00001" attachment-type="cdx" file="US08044046-20111025-C00001.CDX"/><attachment idref="CHEM-US-00001" attachment-type="mol" file="US08044046-20111025-C00001.MOL"/></attachments></chemistry><br/> wherein: <ul><li id="ul0001-0001" num="0000">n is 1 or 2;</li><li id="ul0001-0002" num="0000">R<sup>1 </sup>is hydrogen, C<sub>1</sub>-C<sub>4</sub>-alkyl, halogen, OH, or &#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkyl;</li><li id="ul0001-0003" num="0000">R<sup>2 </sup>is hydrogen, C<sub>1</sub>-C<sub>4</sub>-alkyl, halogen, OH, or &#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkyl;</li><li id="ul0001-0004" num="0000">R<sup>3 </sup>is hydrogen, C<sub>1</sub>-C<sub>4</sub>-alkyl, OH, halogen, &#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkyl, &#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkylene-COOH, or &#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkylene-CO&#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkyl, or <br/> an acid addition salt thereof with a pharmacologically acceptable acid, or a solvate or hydrate thereof; and <br/> a pharmaceutically acceptable excipient or carrier, and methods for using the pharmaceutical formulation in the treatment of chronic obstructive pulmonary disease (COPD). </li></ul> </p>
9 schema:endDate 2023-11-10
10 schema:name Medicaments for the treatment of chronic obstructive pulmonary disease
11 schema:recipient grid-institutes:grid.420061.1
12 schema:sameAs https://app.dimensions.ai/details/patent/US-8044046-B2
13 schema:sdDatePublished 2022-12-01T06:58
14 schema:sdLicense https://scigraph.springernature.com/explorer/license/
15 schema:sdPublisher N768a434cec8a439fb5c7609d4dd47b63
16 sgo:license sg:explorer/license/
17 sgo:sdDataset patents
18 rdf:type sgo:Patent
19 N01c5dd3de8954fdfbddb50062c058e29 schema:name PESTEL SABINE
20 rdf:type schema:Person
21 N24b1a8c6deae4757af6114f3df077980 schema:name RUDOLF KLAUS
22 rdf:type schema:Person
23 N327a528dbcb2472d80d556a6553ea539 rdf:first Nb86d184706514b1aa6535bd339d43ccc
24 rdf:rest Nf142f8bee1544ca996da07592269c1fe
25 N4ce8936cc8ee49faadb1fb1ad0dae2a3 schema:name SCHNAPP ANDREAS
26 rdf:type schema:Person
27 N5247a4ae541b4b27be88a96632d8bcfd rdf:first N4ce8936cc8ee49faadb1fb1ad0dae2a3
28 rdf:rest N784cadf13f7140679bc8979c3a74cefe
29 N5894029b73e943f6916b73e298c72b5e schema:name BUETTNER FRANK
30 rdf:type schema:Person
31 N7530711ea0434302a2f73f4e630cc796 rdf:first N5894029b73e943f6916b73e298c72b5e
32 rdf:rest Nba2e5f859c3c417cb6722f6d6bbcbedb
33 N7672950e87bd43738a4d22d2909d4442 rdf:first N8c03985fc2bf472d8dc12156dfbd9c46
34 rdf:rest N327a528dbcb2472d80d556a6553ea539
35 N768a434cec8a439fb5c7609d4dd47b63 schema:name Springer Nature - SN SciGraph project
36 rdf:type schema:Organization
37 N784cadf13f7140679bc8979c3a74cefe rdf:first Nd19db0978677402d94c9a0827d218c28
38 rdf:rest N7530711ea0434302a2f73f4e630cc796
39 N8c03985fc2bf472d8dc12156dfbd9c46 schema:name KONETZKI INGO
40 rdf:type schema:Person
41 Na2bb241c46b947fea6a8e599b0d71ee5 schema:name LUSTENBERGER PHILIPP
42 rdf:type schema:Person
43 Na5e9f4223eba406ebddbe38da5c11b9e schema:name HOENKE CHRISTOPH
44 rdf:type schema:Person
45 Nb86d184706514b1aa6535bd339d43ccc schema:name SCHROMM KURT
46 rdf:type schema:Person
47 Nba2e5f859c3c417cb6722f6d6bbcbedb rdf:first Nd01cf2702aed469581b001d5294464b0
48 rdf:rest Nd325cb3ab1664b1f9bad931ea8004c96
49 Nbdce4cb0120a464bbb909b45ec35f7a6 schema:name SCHOLLENBERGER HERMANN
50 rdf:type schema:Person
51 Nd01cf2702aed469581b001d5294464b0 schema:name HEINE CLAUDIA
52 rdf:type schema:Person
53 Nd19db0978677402d94c9a0827d218c28 schema:name BOUYSSOU THIERRY
54 rdf:type schema:Person
55 Nd325cb3ab1664b1f9bad931ea8004c96 rdf:first Na2bb241c46b947fea6a8e599b0d71ee5
56 rdf:rest Ne2f7b2b6fd864dfd8a7299fb416c2b3b
57 Nd490080d91f44855ab5c778b71cd2c60 rdf:first N01c5dd3de8954fdfbddb50062c058e29
58 rdf:rest N5247a4ae541b4b27be88a96632d8bcfd
59 Nd8c271cd8e5d459dba6300aaad76a165 rdf:first N24b1a8c6deae4757af6114f3df077980
60 rdf:rest rdf:nil
61 Ne2f7b2b6fd864dfd8a7299fb416c2b3b rdf:first Na5e9f4223eba406ebddbe38da5c11b9e
62 rdf:rest Nd8c271cd8e5d459dba6300aaad76a165
63 Nf142f8bee1544ca996da07592269c1fe rdf:first Nbdce4cb0120a464bbb909b45ec35f7a6
64 rdf:rest Nd490080d91f44855ab5c778b71cd2c60
65 anzsrc-for:34 schema:inDefinedTermSet anzsrc-for:
66 rdf:type schema:DefinedTerm
67 anzsrc-for:3402 schema:inDefinedTermSet anzsrc-for:
68 rdf:type schema:DefinedTerm
69 anzsrc-for:40 schema:inDefinedTermSet anzsrc-for:
70 rdf:type schema:DefinedTerm
71 sg:pub.10.2165/00002018-200427040-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008046870
72 https://doi.org/10.2165/00002018-200427040-00003
73 rdf:type schema:CreativeWork
74 sg:pub.10.2165/00002018-200427100-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048743769
75 https://doi.org/10.2165/00002018-200427100-00001
76 rdf:type schema:CreativeWork
77 grid-institutes:grid.420061.1 schema:Organization
 




Preview window. Press ESC to close (or click here)


...